Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Naloxone hydrochloride 400micrograms/1mL prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride 800micrograms/2mL prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride 400mcg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride 20mcg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride 20mcg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride 400mcg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride 1mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride 2mg/2mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine hydrochloride + naloxone hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride 2mg/2mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) |
Has basis of strength substance (attribute) |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) |
Has basis of strength substance (attribute) |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) |
Has precise active ingredient |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely naloxone hydrochloride 40 microgram/2 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naloxone hydrochloride 40 microgram/2 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naloxone hydrochloride 400 microgram/1 milliliter conventional release solution for injection syringe |
Has precise active ingredient |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naloxone hydrochloride 400 microgram/1 milliliter conventional release solution for injection syringe |
Has basis of strength substance (attribute) |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naloxone hydrochloride 800 microgram/2 milliliter conventional release solution for injection syringe |
Has basis of strength substance (attribute) |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naloxone hydrochloride 800 microgram/2 milliliter conventional release solution for injection syringe |
Has precise active ingredient |
False |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone hydrochloride 400 microgram/mL solution for injection |
Has precise active ingredient |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone hydrochloride 400 microgram/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naloxone hydrochloride 20 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naloxone hydrochloride 20 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) |
Has precise active ingredient |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet |
Has precise active ingredient |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet |
Has basis of strength substance (attribute) |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone hydrochloride dihydrate (substance) |
Is modification of (attribute) |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride 20 mg/mL nasal spray |
Has basis of strength substance (attribute) |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone hydrochloride 20 mg/mL nasal spray |
Has precise active ingredient |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone hydrochloride 40 mg/mL nasal spray |
Has basis of strength substance (attribute) |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone hydrochloride 40 mg/mL nasal spray |
Has precise active ingredient |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naloxone hydrochloride 80 milligram/1 milliliter conventional release nasal spray (clinical drug) |
Has basis of strength substance (attribute) |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naloxone hydrochloride 80 milligram/1 milliliter conventional release nasal spray (clinical drug) |
Has precise active ingredient |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) |
Has precise active ingredient |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naloxone (as naloxone hydrochloride) 1.8 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has precise active ingredient |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone hydrochloride anhydrous (substance) |
Is modification of (attribute) |
True |
Naloxone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|